Home » Topics » Regulatory » Patents

Patents
RSS

CGRP antagonists for the treatment of migraine claimed by Merck & Co.

Oct. 26, 2009

University of California claims IRES inhibitors for the treatment of HCV infection

Oct. 23, 2009

Merck KGaA describes glucokinase activators for the treatment of diabetes

Oct. 23, 2009

Boehringer Ingelheim discloses CB2 receptor agonists for the treatment of pain

Oct. 23, 2009

GlaxoSmithKline discovers novel FAK inhibitors for use as oncolytic agents

Oct. 22, 2009

Novel antithrombotic compounds in early development at sanofi-aventis

Oct. 22, 2009

Merck & Co. claims novel CGRP receptor antagonists for migraine

Oct. 22, 2009

HIF-PH inhibitors in early development at FibroGen described in recent patent

Oct. 21, 2009

Vichem Chemie presents novel selective EGFR inhibitors as oncolytics

Oct. 21, 2009

Sanofi-aventis claims SGLT-2 inhibitors for the treatment of type 1 and type 2 diabetes

Oct. 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...